Echo IQ Limited (ASX:EIQ)
0.3600
+0.0150 (4.35%)
May 2, 2025, 4:10 PM AEST
Echo IQ Company Description
Echo IQ Limited provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom.
It operates through Houston We Have Software and Echo IQ segments. The company offers EchoSolv, an AI software for identification of aortic stenosis heart condition to physicians and healthcare facilities.
It also provides software products and services for the defence and other sectors. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021.
Echo IQ Limited is based in Sydney, Australia.
Echo IQ Limited
Country | Australia |
Industry | Software - Application |
Sector | Technology |
CEO | Dustin Haines |
Contact Details
Address: 477 Pitt Street Sydney, 2000 Australia | |
Phone | 61 2 9159 3719 |
Website | echoiq.ai |
Stock Details
Ticker Symbol | EIQ |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000195430 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Dustin Haines | Chief Executive Officer |
Andrew Grover | Executive Chairman |
Nianh Byrne | Finance Manager |
Philip Woolff | Chief Operating Officer |
Sam Dribin | Chief Technology Officer |
Prof. David Playford | Chief Medical Advisor |
Donald L. Fowler | President of Echo IQ USA |
Deon Strydom | Chief Commercial Officer |
Prof. Geoffrey A. Strange | Chief Research and Strategy Officer |
Jessamyn Sarah Lyons AGIA, B.Com. | Company Secretary and Director |